Announcing a new white paper, "Lupus Community Panel Proposals for Optimizing Clinical Trials: 2018," developed to address critical issues that have stymied the lupus drug development process for decades.
The Omnibus Appropriations bill passed by the US House of Representatives on March 22 includes increased funding for critical lupus research and education programs.
The Lupus Foundation of America announces the election of two new board members, Andrew Brophy and Barbara Polk.
New datasets provide insight for cells in lupus and RA disease tissue.
The collaboration between Exagen and GSK will raise awareness of Exagen's AVISE diagnostic and monitoring tests among healthcare professionals around the world.
Advice on recognizing and managing lupus flares from top rheumatologist.
Registration is now open for the 2018 National Lupus Advocacy Summit, to be held March 20-21, in our nation's capital.
There has been significant progress, not only in awareness, but also in lupus research and advocacy efforts to secure additional research funding for lupus.